InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the full record of transactions filed by ROBIN HOWARD W, Chairman & CEO. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. In total, 11 reports have been recorded. Total volume traded: €859k. The latest transaction was disclosed on 15 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
068,450 shares0
Common Stock
SEC:0001209191-22-029902:0·
€120,33012,480 shares@ €9.64180.0050% mcap47.1% of flow
Common Stock
SEC:0001209191-22-011438·
€120,33012,480 shares@ €9.64180.0050% mcap17.6% of flow
Common Stock
SEC:0001209191-22-011438:0·
0126,050 shares0
Common Stock
SEC:0001209191-21-070692·
0126,050 shares0
Common Stock
SEC:0001209191-21-070692:0·
094,100 shares0
Common Stock
SEC:0001209191-21-065222·
094,100 shares0
Common Stock
SEC:0001209191-21-065222:0·
€135,18911,515 shares@ €11.74030.0057% mcap52.9% of flow
Common Stock
SEC:0001209191-21-052391·
€135,18911,515 shares@ €11.74030.0057% mcap19.7% of flow
Common Stock
SEC:0001209191-21-052391:0·
€174,01511,560 shares@ €15.0532100.0% of flow
Common Stock
SEC:0001209191-21-034187·
€174,01511,560 shares@ €15.05320.0073% mcap25.4% of flow
Common Stock
SEC:0001209191-21-034187:0·
11 of 11 declarations
About ROBIN HOWARD W
ROBIN HOWARD W is the President & CEO at NEKTAR THERAPEUTICS. He is responsible for the strategic direction of the company and oversees all operations. His leadership and expertise in the biopharmaceutical sector are essential for the success of the organization.
